Where Does MRTX Stock Rank in the Biotechnology Industry? – InvestorsObserver

The 57 rating InvestorsObserver gives to Mirati Therapeutics Inc (MRTX) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 75 percent of stocks in the Biotechnology industry, MRTXs 57 overall rating means the stock scores better than 57 percent of all stocks.

Click Here to get the full Stock Score Report on Mirati Therapeutics Inc (MRTX) Stock.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 57 means the stock is more attractive than 57 percent of stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Mirati Therapeutics Inc (MRTX) stock has risen 0.91% while the S&P 500 is lower by -0.23% as of 11:07 AM on Friday, Nov 29. MRTX is up $0.90 from the previous closing price of $99.44 on volume of 61,363 shares. Over the past year the S&P 500 is up 14.93% while MRTX is up 168.50%. MRTX lost -$4.69 per share the over the last 12 months.

To see the top 5 stocks in Biotechnology click here.

Read more from the original source:
Where Does MRTX Stock Rank in the Biotechnology Industry? - InvestorsObserver